Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A...

92
LSU Improving Quality, Improving Outcomes, Improving Efficiency Michael Kaiser, MD Chief Medical Officer LSU Health Care Services Division

Transcript of Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A...

Page 1: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

LSU Improving Quality,

Improving Outcomes,Improving Efficiency

Michael Kaiser, MDChief Medical Officer

LSU Health Care Services Division

Page 2: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Disclosure

I, Michael Kaiser, MD, have no relationships with commercial interests to disclose.

A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

LSU SCHOOL OF MEDICINE-NEW ORLEANS

Page 3: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

The best of times?

Or

The worst of times?

Page 4: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

LSU Medical HomeD

IABE

TES

DIA

BETE

SD

IABE

TES

DIA

BETE

S

CHF

CHF

CHF

CHF

HIVHIV

HIVHIV

KID

NEY

DIS

EASE

KID

NEY

DIS

EASE

CAN

CER

CAN

CER

CAN

CER

CAN

CER

ASTH

MA

ASTH

MA

ASTH

MA

ASTH

MA

THROMBOGENIC STATE CONTROL

BLOOD PRESSURE CONTROL

GLYCEMIC CONTROL

LIPID CONTROL

SMOKING CESSATION

DIET EXERCISE WEIGHT CONTROL

SCREENING

Page 5: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

DIABETES

Page 6: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

1097 1914

1026

20251342

1694

695

9793

.45

.5

.55

.6

.65

.7

.75

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104AWARD criterion = 0.55, GOAL = 0.65, see lines on graph

diabetes: LDL <= 100 [R]denom: PC Sustained, 6/12

Page 7: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

1358

2311

1325

2468

1509

1959

909

11839

.15

.2

.25

.3

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200801 through 201104

diabetes: A1c<7, LDL<100, BP<140/90denom: PC Sustained, 6/12

This is the diabetes “composite” control measure.

Page 8: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

1043

1666

971

1739

1104

1431

645

8599

0

.1

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104AWARD criterion = 0.55, see line on graph

diabetes: Eye exam in past 15 mos [R]denom: PC Sustained, 3/12

Page 9: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

HEART FAILURE

Page 10: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

76251

57

289

267302

1791421

.6

.65

.7

.75

.8

.85

.9

.95

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104AWARD criterion = 0.85, see line on graph

chf: on metop-s, carvedilol, or bisoprolol [R]denom: PC Sustained, 6/12

Page 11: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

84

250

61

297

270

323

193

1478

.2

.25

.3

.35

.4

.45

.5

.55

.6

.65

.7

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104

chf: mod < 130/80, BP in last year [R]denom: PC Sustained, 6/12

Page 12: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

186

318

124

419

370

368

237

2021

.1

.15

.2

.25

.3

.35

.4

.45

.5

.55

.6

.65

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200801 through 201101

admit: IP visits per person year - qrtdenom: CHF clinic population

Our heart failure admission rates have been steadily falling

Page 13: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

12

15

11

14

17

1710

65

0

.1

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104

chf: PC visit w/I 20 days of all-cause IPdenom: lowEF pop 3+ mos

Although we just starting tracking this measure, the fraction of inpatient discharges with PC visits within 30 days has been increasing for some time.

Page 14: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

ASTHMA

Page 15: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

326

307 159

396

260199

160

1807

0

.1

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 201003 through 201104AWARD criterion = 0.80, GOAL = 0.80, see lines on graph

asthma: % with action plan ever [R]denom: Sust PC 3/12, DXconf

Page 16: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

326

307159 396

260199

160 1807

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104AWARD criterion = 0.80, see line on graph

asthma: % with PFT in past 3 yrs [R]denom: Sust PC 3/12, DXconf

Page 17: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

326

307159

396260

199

160

1807

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104GOAL = 0.60, see line on graph

asthma: % with pneumovax imm ever [R]denom: Sust PC 3/12, DXconf

Page 18: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

143

147

65218

13091

78 871

0

.5

1

1.5

2

2.5

3

3.5

4

4.5

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201103

asthma: #ER+IP visits/person-year, quarterdenom: Asthma pop 3+ mos, DXconf

Page 19: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

HYPERTENSION

Page 20: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

4323

6732

4036

5637

6256 7189

4303

38476

.2

.25

.3

.35

.4

.45

.5

.55

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201103

htn: Curr BP >= 140/90denom: PC Sustained, 3/12

Page 21: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

4081

6425

3826

5318

59176867

4091 36525

.1

.15

.2

.25

.3

.35

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201103

htn: Sustained BP > 140/90denom: PC Sustained, 3/12

Page 22: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

CHRONIC KIDNEY DISEASE

Page 23: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

254 316260

493

363

443

211

2340

.4

.45

.5

.55

.6

.65

.7

.75

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104AWARD criterion = 0.65, see line on graph

renal: LIPIDS, LDL < 100, stage 34conf [R]denom: PC sustained 6/12

Page 24: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

324

401

336582

421519

306

2889

.2

.25

.3

.35

.4

.45

.5

.55

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104AWARD criterion = 0.40, GOAL = 0.40, see lines on graph

renal: BP, last BP < 130/80, stage 34conf [R]denom: PC sustained 6/12

Page 25: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

CANCER SCREENING

Page 26: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

2725

5013 3216 4728

4814

5609

3586

29691

.5

.55

.6

.65

.7

.75

.8

.85

.9

.95

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200703 through 201104AWARD criterion = 0.80, GOAL = 0.80, see lines on graph

breastcancer: Mammogram in past 2 years, age 40-75 [R]denom: PC Sustained, 6/12

Page 27: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

2198

5391

1667

3649

4538 4899

3141

25483

.45

.5

.55

.6

.65

.7

.75

.8

.85

.9

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104AWARD criterion = 0.80, GOAL = 0.80, see lines on graph

cervicalcancer: Pap in 2 yrs (21-29) or 3 yrs (30-69) [R]denom: PC Sustained, 6/12

Page 28: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

3104

5000

3005

4191

5018

5440

352929287

.2

.25

.3

.35

.4

.45

.5

.55

.6

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104AWARD criterion = 0.50, see line on graph

coloncancer: Scope_10yr OR flexsig_5yr OR FOBT_1yr [R]denom: PC Sustained, 3/12

Page 29: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

HIV

Page 30: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

64

53493

132

607

270193 1893

.3

.4

.5

.6

.7

.8

.9

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104

hiv: current viral load undetectabledenom: HIV clinic 3/12 sustained

Page 31: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

64

52795 136

613 274 201 1910

0

.1

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104AWARD criterion = 0.80, GOAL = 0.80, see lines on graph

hiv: STDs, Chlamydia test in past 15 mos [R]denom: HIV clinic 3/12 sustained

Page 32: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

18

235

13

36

168 86

54610

.1

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104

hiv: Pap in 2 yrs (21-29) or 3 yrs (30-69)denom: HIV clinic 3/12 sustained

Page 33: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

18 152

23

28

154

56

31

462

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200703 through 201104

hiv: mammogram in past 2 yearsdenom: HIV clinic 3/12 sustained

Page 34: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

TOBACCO CONTROL

Page 35: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

6427

9065

51387235 11723 9567

582654981

0

.1

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLHPL

LAK

LJC

MCL

UMC

WOM

_TOT

SITES over QUARTERSGraph uses data from quarters 200801 through 201104AWARD criterion = 0.90, GOAL = 0.90, see lines on graph

tobacco: screening rate in past 90 days [R]denom: PC visit in past 3 month

Page 36: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

358

235

86342

652

547

206

2426

.4

.5

.6

.7

.8

.9

1

SITES over QUARTERSGraph uses data from quarters 200901 through 201104AWARD criterion = 0.70, GOAL = 0.70, see lines on graph

tobacco: % selected assistance among smokers ready to quit [R]denom: PC visit in past 3 month

This is the fraction of “ready to quit” smokers who select some sort of assistance.

Page 37: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

EMERGENCY DEPARTMENT

Page 38: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

3617

4455

3885

40654543 4615

3292 28476

0

100

200

300

400

500

600

BMC

EKLHPL

LAK

LJC

MCL

UMC

WOM

_TOT

SITES over QUARTERSGraph uses data from quarters 200801 through 201104

ed: LOS, home, triage 4&5 (Median)denom: Non-BH in quarter

This is median LOS (in minutes) for non-behavior health patients, discharged to home, with triage levels 4 & 5

Page 39: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

MEDICAL HOME

Page 40: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

14947.00

21690.00

12100.00

20838.00

26071.00

24780.00

13755.00

10000

12000

14000

16000

18000

20000

22000

24000

26000

28000

BMC

EKLLA

KLJ

CM

CLUM

CW

OM

Graph combines data from quarters 201104 through 201104.Bottom row numbers on graph are sample sizes.

mh: # in denominatorDENOM: Total PC clinic population

These are our current medical home patient population estimates. The system-wide total is 134,181. These are likely rather conservative estimate.

Page 41: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Initial State – Analytic Assignment

Page 42: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Medical Home CorrectVerified at Each Visit

Page 43: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

0

.1

.2

.3

.4

.5

.6

.7

.8

.9

1

Average Clinic TOPBOX Fractions and Rangesall respondents

First set of results from the new medical home patient perceptions instrument. Our most positive perceptions were on “friendly.” The least positive pertained to wait times in the clinic (i.e., time spent between arrival and seeing the doctor.)

Page 44: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

CHALLENGES• Pelican Implementation• Medicaid Managed Care• Behavioral Health Managed Care• Obama Care• Value-Based Purchasing and hundreds of new

measures and reporting requirements• Budget Cuts

Page 45: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Do More with Less?

Or

Do Less with Less?

Page 46: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

• Numbers we serve – throughput• Reduce delays in primary care• Decrease utilization of ED for primary care

and primary support

Page 47: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,
Page 48: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

• From ED Medical Home

• From Inpatient Medical Home• From Medical Home Specialty• From Specialty Medical Home

Page 49: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,
Page 50: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

• Patient self-management skills• Medication adherence• Disease Education• Goal setting and behavior change• System navigation

IMPROVE INTERACTIONS WITH OUR PATIENTS

Page 51: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

PatientOur Vision

Value Leader

Our MissionTreat and Teach

Our Values Information Innovation ImprovementIntegrity

Tactics

ResourcesTeaching Research Revenue

Access Quality Safety SatisfactionService

Foundational ElementsMedicalHome

IntegratedInfo Systems

Disease Management Centers of Excellence

PerformanceImprovement

Low Cost Distributed ServicesHigh Quality

Excellence Equity Execution ExplainableEmpathetic

LSU Hospitals ---------------

Strategic Overview

Page 52: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

BETTER UNDERSTANDING AND RESEARCH OF

QUALITY IMPROVEMENT PRACTICES

Page 53: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Transition Care InteractionsSelf Management Education Interaction

Coordinated Care Interactions

EVIDENCE BASED STRATEGIES

Page 54: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

COORDINATED CARE INTERACTIONS

• Targeting• In-person contact• Access to timely information on hospital and ER

admissions• Close interaction between care coordinators and

primary care physicians• Patient assessment, planning, education, monitoring,

and coaching with social support

Page 55: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

1358

2311

1325

2468

1509

1959

909

11839

.2

.3

.4

.5

.6

.7

.8

.9

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104

diabetes: IMM, flu immunization this seasondenom: PC Sustained, 6/12

Page 56: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

64527 95

136613 274

2011910

.45

.5

.55

.6

.65

.7

.75

.8

.85

.9

.95

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104

hiv: STDs, syphilis test in past 15 mos [R]denom: HIV clinic 3/12 sustained

Page 57: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

CLIQ Documentation

Page 58: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

557

595

380

814

635

766

364 4111

0

.1

.2

.3

.4

.5

.6

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200801 through 201104

documentation: DX, asthma DX confirmeddenom: PC Sustained, 3/12

Page 59: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

68182

38

207

193247

161 1096

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104

documentation: DX, heart failure DX confirmeddenom: PC Sustained, 3/12

Page 60: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

27095

37687

20785

31437

49304

4056922055 228932

0

.1

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200804 through 201104

documentation: MEDREC, fraction with medrec donedenom: PC patients in qrt

Page 61: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

1769525595 15208

20653

33383 2705516958

156547

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200703 through 201104

documentation: PP, fraction with blood pressure documenteddenom: PC patients in qrt

Page 62: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

684710615 6537

8832

13470

9897

5729

68842

0

.1

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLHPL

LAK

LJC

MCL

UMC

WOM

_TOT

SITES over QUARTERSGraph uses data from quarters 200801 through 201104

ed: ED summary & dictation rate [R]denom: All ED visits in quarter

Page 63: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Current Plan

Currently we are planning to develop measures in the following domains:

1. Patient engagement2. Access to primary care3. Access to specialty care4. Primary care efficiency5. Wellness6. Chronic disease management7. Reduction of adverse events 8. Patient perceptions of MH experiences9. Provider perceptions of MH experiences

Our current medical home measures plan calls for measures in these 9 domains. The next five slides show five initial measures now being added to the site visit reports.

Page 64: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

3749

5514

3066

5294

6712

6283

3508

34127

0

.1

.2

.3

.4

.5

.6

.7

.8

.9

1

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200701 through 201104

mh: ER visits per person-year - qrt, x-IPdenom: Total PC clinic population

This is our ED visit rate per person-year for the total medical home patient population.

Page 65: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

939

973

626

985

1331 1214

650

6718

0

10

20

30

40

50

60

70

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200801 through 201103

mh: Median time to appointment denom: new patients in quarter

This is the median days to wait for a new patient appointment

Page 66: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

2609

3732

2514

2829

3225

5300

1538

21747

0

10

20

30

40

50

60

70

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200801 through 201103

mh: Median time to appointment denom: established patients in quarter

This is the median days to wait for a non-follow-up appointment for established patients.

Page 67: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

940

973

626

985

1331

1214 650

6719

.55

.6

.65

.7

.75

.8

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200801 through 201103

mh: Show rate denom: new patients in quarter

Page 68: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

2610 3733

2515

2829

3226

5300

1538

21751

.55

.6

.65

.7

.75

.8

.85

BMC

EKLLA

KLJ

CM

CLUM

CW

OM_T

OT

SITES over QUARTERSGraph uses data from quarters 200801 through 201103

mh: Show rate denom: established patients in quarter

Page 69: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Medical Home:Satisfaction & Patient Perceptions

• We continue to use our patient satisfaction survey which assessed post-visit impressions of the recent visit.

• We have begun using a “medical home patient perceptions” survey.– Conducted in clinics prior to visits– Assesses perceptions among existing (not new)

medical home patients– Summarized quarterly, based on surveys done one or

two days per month by each MH clinic.

Page 70: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Medical Home Designation and Documentation

CLIQ Summary Screen Update

CLIQ Powered by:LSU HCSD Medical Informatics Team

Page 71: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Initial State – No Medical Home

Page 72: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Medical Home Fields Blank

Page 73: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Medical Home Fields Populated

Page 74: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Two Initial States

Page 75: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Documenting A Medical Home

Page 76: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

CommCare Medical Home

Page 77: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

LSU Medical Home

Page 78: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Non-LSU Medical Home

Page 79: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

LSU Medical Home

Page 80: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

LSU Medical Home

Page 81: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

LSU Medical Home

Page 82: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

LSU Medical Home

Page 83: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

LSU Medical Home

Page 84: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Updating/Viewing Medical Home Data

Page 85: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

Questions

Page 86: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,
Page 87: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,
Page 88: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,
Page 89: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,
Page 90: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,
Page 91: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,
Page 92: Disclosure I, Michael Kaiser, MD, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing,

PatientOur Vision

Value Leader

Our MissionTreat and Teach

Our Values Information Innovation ImprovementIntegrity

Tactics

ResourcesTeaching Research Revenue

Access Quality Safety SatisfactionService

Foundational ElementsMedicalHome

IntegratedInfo Systems

Disease Management Centers of Excellence

PerformanceImprovement

Low Cost Distributed ServicesHigh Quality

Excellence Equity Execution ExplainableEmpathetic

LSU Hospitals ---------------

Strategic Overview